Loading...
| A03843 | Pages: NA | Dec 2021 | 4729 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Global Sleep Disorder Treatment Drugs Market
Request Now !Sleep disorder or insomnia is a medical disorder in which the patient has difficulty with sleep maintenance or sleep initiation. This disorder causes irregular mental, physical, social, and emotional functions.
Factors such as increasing incidences of depression & other medical disorders, late night working schedule, busy lifestyle, lack of quality sleep, and rising geriatric population drive the market growth. However, patent expirations of major sleep disorder treatment drugs and side effects associated with these drugs such as restlessness & nausea restrain the market growth. Moreover, introduction of home sleep test kits and utilization of wearable monitors & continuous positive airway pressure (CPAP) therapy increase opportunities for the market growth.
The sleep disorder treatment drugs market is segmented on the basis of sleep disorder, product, medication, and region. On the basis of sleep disorder, it is segmented into insomnia, sleep apnea, restless legs syndrome, narcolepsy, and sleep walking. On the basis of product, it is segmented into mattresses & pillows, sleep laboratories, medications, and sleep apnea devices. On the basis of medication, it is segmented into prescription-based drugs, OTC drugs, and herbal drugs. Geographically, the market has been analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The key players in the market include Pfizer Inc, Sanofi, Merck & Co Inc, GlaxoSmithKline plc, Koninklijke Philips N.V., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Cardinal Health, Becton Dickson and Company, and Natus Medical Incorporated.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities
CHAPTER 4 GLOBAL SLEEP DISORDER TREATMENT DRUGS MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. MATTRESSES AND PILLOWS
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. SLEEP LABORATORIES
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. MEDICATIONS
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.5. SLEEP APNEA DEVICES
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
CHAPTER 5 GLOBAL SLEEP DISORDER TREATMENT DRUGS MARKET, BY SLEEP DISORDER
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. INSOMNIA
5.2.1. Market size and forecast
5.3. SLEEP APNEA
5.3.1. Market size and forecast
5.4. RESTLESS LEGS SYNDROME
5.4.1. Market size and forecast
5.5. NARCOLEPSY
5.5.1. Market size and forecast
5.6. SLEEP WALKING
5.6.1. Market size and forecast
CHAPTER 6 GLOBAL SLEEP DISORDER TREATMENT DRUGS MARKET, BY MEDICATION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. PRESCRIPTION-BASED DRUGS
6.2.1. Market size and forecast
6.3. OTC DRUGS
6.3.1. Market size and forecast
6.4. HERBAL DRUGS
6.4.1. Market size and forecast
CHAPTER 7 GLOBAL SLEEP DISORDER TREATMENT DRUGS MARKET, BY REGION
7.1. OVERVIEW
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast
7.2.4. North America Sleep Disorder Treatment Drugs Market, by Sleep Disorder
7.2.5. North America Sleep Disorder Treatment Drugs Market, by Product
7.2.6. North America Sleep Disorder Treatment Drugs Market, by Medication
7.3. EUROPE
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast
7.3.4. Europe Sleep Disorder Treatment Drugs Market, by Sleep Disorder
7.3.5. Europe Sleep Disorder Treatment Drugs Market, by Product
7.3.6. Europe Sleep Disorder Treatment Drugs Market, by Medication
7.4. ASIA-PACIFIC
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. India market size and forecast
7.4.3.4. Rest of Asia-Pacific market size and forecast
7.4.4. Asia-Pacific Sleep Disorder Treatment Drugs Market, by Sleep Disorder
7.4.5. Asia-Pacific Sleep Disorder Treatment Drugs Market, by Product
7.4.6. Asia-Pacific Sleep Disorder Treatment Drugs Market, by Medication
7.5. LAMEA
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.3.1. Brazil market size and forecast
7.5.3.2. Saudi Arabia market size and forecast
7.5.3.3. South Africa market size and forecast
7.5.3.4. Rest of LAMEA market size and forecast
7.5.4. LAMEA Sleep Disorder Treatment Drugs Market, by Sleep Disorder
7.5.5. LAMEA Sleep Disorder Treatment Drugs Market, by Product
7.5.6. LAMEA Sleep Disorder Treatment Drugs Market, by Medication
CHAPTER 8 COMPANY PROFILES
8.1. PFIZER INC
8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments
8.2. SANOFI
8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments
8.3. GLAXOSMITHKLINE PLC _
8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments
8.4. MERCK & CO INC.
8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments
8.5. KONINKLIJKE PHILIPS N.V.
8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments
8.6. TAKEDA PHARMACEUTICAL COMPANY LIMITED
8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments
8.7. TEVA PHARMACEUTICAL INDUSTRIES LTD.
8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments
8.8. CARDINAL HEALTH
8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments
8.9. BECTON DICKSON AND COMPANY
8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments
8.10. NATUS MEDICAL INCORPORATED
8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
